We identified NPM1, which is highly expressed in cancer cells, as a novel factor interacting with p27 and confirmed that the increased expression of NPM1 in cancer cells suppresses p27 function and promotes cell proliferations in vitro and in vivo. Here, CDKN1B is linked to cancer.